UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Causality in medicine: the case of tumours and viruses

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2000-12, Vol.355 (1404), p.1831

Vonka, V

2000

Link zum Volltext

Verfügbarkeit prüfen

The Relationship of Kynurenine and Neopterin Levels and Their Association with a Selection of Other Immune Markers in Chronic Myeloid Leukaemia Patients

Folia biologica, 2016-01, Vol.62 (6), p.235-240

2016

Link zum Volltext

Verfügbarkeit prüfen

Isolation and properties of gene-modified mouse bcr-abl-transformed cells expressing various immunostimulatory factors

Neoplasma, 2009, Vol.56 (3), p.194

2009

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo effects of reovirus on HPV16-transformed mice cells

Neoplasma, 2010, Vol.57 (3), p.207

2010

Link zum Volltext

Verfügbarkeit prüfen

Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16

British journal of cancer, 2001-02, Vol.84 (3), p.374-380

2001

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours

International journal of oncology, 2003-07, Vol.23 (1), p.243

2003

Link zum Volltext

Verfügbarkeit prüfen

Use of polyclonal rabbit antibodies for detection of the bcr-abl fusion zone in cells transfected with experimental bcr-abl DNA vaccines

International journal of oncology, 2005-07, Vol.27 (1), p.265

2005

Link zum Volltext

Verfügbarkeit prüfen

Will vaccines appear on the scene of oncology in the near future?

Vnitřní lékar̆stvĭ, 2010-07, Vol.56 (7), p.739-746

Vonka, V

2010

Link zum Volltext

Verfügbarkeit prüfen

Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions

Sexually transmitted infections, 2003-06, Vol.79 (3), p.191-196

2003

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer

Journal of clinical oncology, 1997-02, Vol.15 (2), p.610-619

1997

Link zum Volltext

Verfügbarkeit prüfen

Measurement of secondary flow vortices in a rod bundle

Nuclear engineering and design, 1988-02, Vol.106 (2), p.191-207

Vonka, V

1988

Link zum Volltext

Verfügbarkeit prüfen

Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules

Vaccine, 2003-03, Vol.21 (11), p.1125-1136

2003

Link zum Volltext

Verfügbarkeit prüfen

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

Virology (New York, N.Y.), 2001-03, Vol.281 (2), p.231-238

2001

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects

Folia biologica, 2004, Vol.50 (6), p.184-184

2004

Link zum Volltext

Verfügbarkeit prüfen

DNA vaccination against bcr-abl-positive cells in mice

International journal of oncology, 2009-10, Vol.35 (4), p.941-951

2009

Link zum Volltext

Verfügbarkeit prüfen

Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide

International journal of molecular medicine, 2001-01, Vol.7 (1), p.97

2001

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A

Oncology reports, 2001-11, Vol.8 (6), p.1371

2001

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus vaccines

Folia biologica, 1996, Vol.42 (3), p.73

Vonka, V

1996

Link zum Volltext

Verfügbarkeit prüfen

Bcr-Abl fusion sequences do not induce immune responses in mice when administered in mouse polyomavirus based virus-like particles

International journal of oncology, 2009-12, Vol.35 (6), p.1247-1256

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunological profiles of patients with chronic myeloid leukaemia. I. State before the start of treatment

Folia biologica, 2006-01, Vol.52 (3), p.47-58

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of 3-β-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants

Archives of virology, 1998-01, Vol.143 (7), p.1311-1320

1998

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells

International journal of oncology, 2008-08, Vol.33 (2), p.421-426

2008

Link zum Volltext

Verfügbarkeit prüfen

MHC class I+ and class I- HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments

Folia biologica, 2003, Vol.49 (6), p.230-234

2003

Link zum Volltext

Verfügbarkeit prüfen

Local IFN-gamma therapy of HPV16-associated tumours

Folia biologica, 2003, Vol.49 (1), p.26-32

2003

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: cytolytic activity of spleen cells from tumour regressors

Folia biologica, 2003, Vol.49 (6), p.217-222

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(326)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Causality in medicine: the case of tumours and viruses

The Relationship of Kynurenine and Neopterin Levels and Their Association with a Selection of Other Immune Markers in Chronic Myeloid Leukaemia Patients

Isolation and properties of gene-modified mouse bcr-abl-transformed cells expressing various immunostimulatory factors

In vitro and in vivo effects of reovirus on HPV16-transformed mice cells

Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16

Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours

Use of polyclonal rabbit antibodies for detection of the bcr-abl fusion zone in cells transfected with experimental bcr-abl DNA vaccines

Will vaccines appear on the scene of oncology in the near future?

Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer

Measurement of secondary flow vortices in a rod bundle

Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects

DNA vaccination against bcr-abl-positive cells in mice

Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide

Chemoimmunotherapy of cancer: potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A

Human papillomavirus vaccines

Bcr-Abl fusion sequences do not induce immune responses in mice when administered in mouse polyomavirus based virus-like particles

Immunological profiles of patients with chronic myeloid leukaemia. I. State before the start of treatment

Effect of 3-β-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants

Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells

MHC class I+ and class I- HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments

Local IFN-gamma therapy of HPV16-associated tumours

Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: cytolytic activity of spleen cells from tumour regressors

Suchergebnisse filtern